Real-world Efficacy, Roll-out and Uptake of Intramuscular Tixagevimab/cilgavimab As COVID-19 Pre-Exposure Prophylaxis in People with Multiple Sclerosis and Neuroimmunological Conditions During the COVID-19 Pandemic
BMJ NEUROLOGY OPEN(2024)
Key words
MULTIPLE SCLEROSIS,COVID-19,HEALTH POLICY & PRACTICE
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined